SNA
52
2
STZ
42
-2
HCA
64
5
APD
45
-2
C
82
3
PSX
37
2
JBHT
65
2
ILMN
73
4
GM
85
2
LLY
71
3
ED
37
-6
CME
45
3
ALLE
44
3
NI
65
-2
NOC
54
6
KR
37
-5
PYPL
52
2
APA
53
5
NWSA
64
-15
AMG
77
3
SNA
52
2
STZ
42
-2
HCA
64
5
APD
45
-2
C
82
3
PSX
37
2
JBHT
65
2
ILMN
73
4
GM
85
2
LLY
71
3
ED
37
-6
CME
45
3
ALLE
44
3
NI
65
-2
NOC
54
6
KR
37
-5
PYPL
52
2
APA
53
5
NWSA
64
-15
AMG
77
3
Financhill
Back

Rayliant Quantitative Developed Market Equity ETF Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison

Sell
50

RAYD
Rayliant Quantitative Developed Market Equity ETF

Last Price:
$37.55
Seasonality Move:
3.83%
Buy
54

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$61.19
Seasonality Move:
5.52%
Sell
50
Rayliant Quantitative Developed Market Equity ETF (RAYD) is a Sell

Is Rayliant Quantitative Developed Market Equity ETF a Buy, Sell or Hold?

  • The current Rayliant Quantitative Developed Market Equity ETF [RAYD] share price is $38.45. The Score for RAYD is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • RAYD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN) is a Buy

Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RAYD Stock Price Chart

What is Rayliant Quantitative Developed Market Equity ETF's stock price today?

  • The Rayliant Quantitative Developed Market Equity ETF share price today is $38.45
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAYD is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Stock Price Chart

What is BioMarin Pharmaceutical, Inc.'s stock price today?

  • The BioMarin Pharmaceutical, Inc. share price today is $61.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.

RAYD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.16 Buy
Relative Strength Index (14 RSI): 57.19 Buy
Chaikin Money Flow: 1597 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.92 - 38.22) Buy
Bollinger Bands (100): (36.76 - 37.96) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 73.39 Buy
Chaikin Money Flow: 7836963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.19 - 56.01) Buy
Bollinger Bands (100): (52.65 - 57.43) Buy

RAYD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.19 Buy
20-day SMA: 37.68 Buy
50-day SMA: 37.59 Buy
200-day SMA: 35.63 Buy
8-day EMA: 20.15 Buy
20-day EMA: 9.86 Buy
50-day EMA: 4.3 Buy
200-day EMA: 1.12 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.6 Buy
20-day SMA: 54.21 Buy
50-day SMA: 53.61 Buy
200-day SMA: 57.94 Buy
8-day EMA: 54.44 Buy
20-day EMA: 53.99 Buy
50-day EMA: 54.1 Buy
200-day EMA: 58.28 Buy

Rayliant Quantitative Developed Market Equity ETF Earnings Growth & RAYD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.68 per share.

Rayliant Quantitative Developed Market Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):